Most people have heard of weight loss drugs like Ozempic, Wegovy, and Mounjaro, which are now being hailed as a way to lose weight easily. However, the company has warned that fake versions of the drug, which is usually prescribed for diabetes, are now more common.
As medications can now be purchased online, some of the Ozempic products are coming from unlicensed sources, making them easy to misbrand. The risks are that they could be counterfeit, contaminated with other substances, or not stored or transported properly.
Novo Nordisk, the manufacturer of Ozempic, has warned that some cheap counterfeits of the product often contain a different type of diabetes medicine that works differently. This can cause an adverse reaction in some cases, as well as potentially being unsafe or ineffective.
In a statement, the company warned consumers about the risks of fake products, saying, “The safety or efficacy of counterfeit products cannot be assured and they should not be used. Potential risks of taking a counterfeit medicine include serious adverse events.”
Novo also detailed some of the ways consumers can spot a fake product.
It says that genuine products don’t extend when the dose is being set and the dose dial window only shows the intended doses, which should be:
These are the only doses available in genuine products, so those with other doses are likely to be fake. Additionally, the 1mg and 2mg products include 4 needles and the 0.25/0/5mg products should always contain 6 needles.
Some other signs that a product is a counterfeit include:
After coming under pressure from consumers, regulations in the Food & Beverage sector are changing…
With inflation and rising living costs affecting more consumers, the issue of ‘shrinkflation’ is becoming…
The Environmental Protection Agency (EPA) has announced a ban on methylene chloride in products for…
Ozempic and other GLP-1 drugs are usually prescribed to treat diabetes. Recently, the endorsement of…
Grindr, the world's largest dating app catering to the LGBTQ+ community, now faces legal action…
At least two states have seen people hospitalised with symptoms resembling botulism after undergoing cosmetic…